We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Aro Biotherapeutics

News List

Aro Biotherapeutics signs licensing agreement worth up to $1.4bn pharmaceutical-technology
January 13, 2020
Aro Biotherapeutics, a biotech firm engaged in the development of protein biologics called Centyrins, has signed a licencing deal that can potentially generate up to $1.4bn for the company.
Janssen alums' Aro Biotherapeutics takes aim at centyrins with $13M round fiercebiotech
December 27, 2018
A pair of former Janssen R&D leaders founded Aro Biotherapeutics early this year to develop centyrins—small proteins that could potentially work like antibodies without the accompanying challenges.....
Isogenica inks licensing deal with Aro Biotherapeutics for development of scaffold molecules fiercebiotech
July 31, 2018
Isogenica has inked a licensing deal with Aro Biotherapeutics to use its in vitro polypeptide display systems for the development of Aro’s scaffold molecule technology.